Premier Partners logo

Premier Partners

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Premier Partners is a prominent South Korean investment firm headquartered in Seoul, recognized for its dual focus on venture capital (VC) and private equity (PE). Established as a domestic funds management company, it has grown to become a significant player in the Korean investment landscape, providing capital and strategic support to a diverse range of companies.

The firm employs a comprehensive investment strategy, targeting high-growth opportunities across various sectors including technology, media, telecommunications, healthcare, and consumer goods. Premier Partners invests across different stages of a company's lifecycle, from early-stage startups requiring initial venture capital to more mature, pre-IPO companies seeking growth equity. As of late 2023, Premier Partners manages assets exceeding ₩2 trillion, equivalent to approximately $1.5 billion USD, underscoring its substantial financial capacity and market presence.

Premier Partners' "two-track" approach allows for flexibility in its investment size and scope. For its venture capital arm, typical first cheques are directed towards promising early to mid-stage companies. Concurrently, its private equity division focuses on larger, more established businesses, often providing significant capital for expansion, strategic acquisitions, or pre-IPO rounds. For instance, the firm successfully raised a ₩200 billion (approximately $150 million USD) growth-focused fund in 2022, demonstrating its commitment to scaling innovative companies. This dual strategy enables Premier Partners to cater to a broad spectrum of investment opportunities, from nascent ventures to market leaders.

Investor Profile

Premier Partners has backed more than 27 startups, with 9 new investments in the last 12 months alone. The firm has led 3 rounds, about 11% of its total and boasts 20 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in South Korea, United States.
  • Strong thematic focus on Artificial Intelligence (AI), Biotechnology, Health Care.
  • Led 1 rounds in the past year.
  • Typical check size: $1M – $30M.

Stage Focus

  • Series B (44%)
  • Series A (30%)
  • Series Unknown (11%)
  • Series C (11%)
  • Corporate Round (4%)

Country Focus

  • South Korea (63%)
  • United States (30%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Health Care
  • Machine Learning
  • Software
  • Therapeutics
  • Natural Language Processing
  • Beauty
  • E-commerce
  • Computer Vision
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Premier Partners frequently co-invest with?

Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Korea Development Bank
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
DSC Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
Aju IB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Yeoksamdong
Co-Investments: 3
Shinhan Venture Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 4
Kiwoom Investment
Asia, Seoul-t'ukpyolsi, South Korea, Youidodong
Co-Investments: 3
Company K Partners
Asia, Seoul-t'ukpyolsi, South Korea, Ilsangu
Co-Investments: 3
KT Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

What are some of recent deals done by Premier Partners?

Law&Company

Seoul, Seoul-t'ukpyolsi, South Korea

Law&Company provide LawTalk service to solve information asymmetry and illegal legal broker of Korean legal market.

Information ServicesLaw EnforcementLegalLegal Tech
Series CJul 15, 2025
Amount Raised: $36,206,333
Celltrio

Fremont, California, United States

Celltrio is a manufacturer of cell culturing automation and biobanking solutions.

Information TechnologyManufacturingRobotics
Series UnknownJun 17, 2025
Amount Raised: $15,000,000

Medisolar, a customized food care solution company

Health CareNutrition
Series AApr 3, 2025
Amount Raised: $8,859,520
Prazer Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Prazer Therapeutics is a biotechnology company that generates novel therapeutics for refractory diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 1, 2025
Amount Raised: $19,728,977
Healing Paper

Seocho, Seoul-t'ukpyolsi, South Korea

Healing Paper uses ICT to improve medical service access, reduce costs, and balance information between experts and non-experts.

BeautyHealth CareMedicalmHealth
Series CFeb 17, 2025
Amount Raised: $29,702,535
Gangnam Unni

Seoul, Seoul-t'ukpyolsi, South Korea

Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and plastic surgery hospital.

BeautyCosmetic SurgeryMedicalWellness
Series CFeb 17, 2025
Amount Raised: $29,702,535

MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases.

BiotechnologyHealth CarePharmaceutical
Series BOct 21, 2024
Amount Raised: $10,889,383
AIGEN Sciences

Seoul, Seoul-t'ukpyolsi, South Korea

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI)BiotechnologyPharmaceuticalProduct Research
Series AOct 16, 2024
Amount Raised: $8,794,744
Lucas

Yeoksamdong, Seoul-t'ukpyolsi, South Korea

Lucas develops a system to detect, measure, categorize and track nodules in the screening CT images.

Medical DeviceSoftware
Series BOct 2, 2024
Amount Raised: $5,282,560
Superb AI

San Mateo, California, United States

End-to-end training data platform that automates data preparation at scale and makes building datasets quick, systematic, and repeatable.

Artificial Intelligence (AI)Computer VisionMachine LearningNatural Language ProcessingSaaS
Series CSep 26, 2024
Amount Raised: $10,272,409